Literature DB >> 21164131

Proteomic temporal profile of human brain endothelium after oxidative stress.

Mingming Ning1, David A Sarracino, Alvin T Kho, Shuzhen Guo, Sun-Ryung Lee, Bryan Krastins, Ferdinando S Buonanno, Juan A Vizcaíno, Sandra Orchard, David McMullin, Xiaoying Wang, Eng H Lo.   

Abstract

BACKGROUND AND
PURPOSE: because brain endothelial cells exist at the neurovascular interface, they may serve as cellular reporters of brain dysfunction by releasing biomarkers into the circulation.
METHODS: we used proteomic techniques to screen conditioned media from human brain endothelial cultures subjected to oxidative stress induced by nitric oxide over 24 hours. Plasma samples from human stroke patients were analyzed by enzyme-linked immunosorbent assay.
RESULTS: in healthy endothelial cells, interaction mapping demonstrated cross-talk involving secreted factors, membrane receptors, and matrix components. In oxidatively challenged endothelial cells, networks of interacting proteins failed to emerge. Instead, inflammatory markers increased, secreted factors oscillated over time, and endothelial injury repair was manifested as changes in factors related to matrix integrity. Elevated inflammatory markers included heat shock protein, chemokine ligand-1, serum amyloid-A1, annexin-A5, and thrombospondin-1. Neurotrophic factors (prosaposin, nucleobindin-1, and tachykinin precursors) peaked at 12 hours, then rapidly decreased by 24 hours. Basement membrane components (fibronectin, desomoglein, profiling-1) were decreased. Cytoskeletal markers (actin, vimentin, nidogen, and filamin B) increased over time. From this initial analysis, the high-ranking candidate thrombospondin-1 was further explored in human plasma. Acute ischemic stroke patients had significantly higher thrombospondin-1 levels within 8 hours of symptom onset compared to controls with similar clinical risk factors (659 ± 81 vs 1132 ± 98 ng/mL; P<0.05; n=20).
CONCLUSIONS: screening of simplified cell culture systems may aid the discovery of novel biomarkers in clinical neurovascular injury. Further collaborative efforts are warranted to discover and validate more candidates of interest.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21164131      PMCID: PMC3696517          DOI: 10.1161/STROKEAHA.110.585703

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  24 in total

Review 1.  The human plasma proteome: history, character, and diagnostic prospects.

Authors:  N Leigh Anderson; Norman G Anderson
Journal:  Mol Cell Proteomics       Date:  2002-11       Impact factor: 5.911

2.  Proinflammatory cytokines and early neurological worsening in ischemic stroke.

Authors:  N Vila; J Castillo; A Dávalos; A Chamorro
Journal:  Stroke       Date:  2000-10       Impact factor: 7.914

3.  Clinical proteomics: written in blood.

Authors:  Lance A Liotta; Mauro Ferrari; Emanuel Petricoin
Journal:  Nature       Date:  2003-10-30       Impact factor: 49.962

Review 4.  Neurovascular regulation in the normal brain and in Alzheimer's disease.

Authors:  Costantino Iadecola
Journal:  Nat Rev Neurosci       Date:  2004-05       Impact factor: 34.870

Review 5.  The blood-brain barrier/neurovascular unit in health and disease.

Authors:  Brian T Hawkins; Thomas P Davis
Journal:  Pharmacol Rev       Date:  2005-06       Impact factor: 25.468

Review 6.  Reactive oxygen radicals in signaling and damage in the ischemic brain.

Authors:  P H Chan
Journal:  J Cereb Blood Flow Metab       Date:  2001-01       Impact factor: 6.200

7.  Temporal profile of matrix metalloproteinases and their inhibitors after spontaneous intracerebral hemorrhage: relationship to clinical and radiological outcome.

Authors:  José Alvarez-Sabín; Pilar Delgado; Sònia Abilleira; Carlos A Molina; Juan Arenillas; Marc Ribó; Esteban Santamarina; Manolo Quintana; Jasone Monasterio; Joan Montaner
Journal:  Stroke       Date:  2004-04-15       Impact factor: 7.914

8.  Temporal profile of angiogenesis and expression of related genes in the brain after ischemia.

Authors:  Takeshi Hayashi; Nobuo Noshita; Taku Sugawara; Pak H Chan
Journal:  J Cereb Blood Flow Metab       Date:  2003-02       Impact factor: 6.200

Review 9.  Tumor progression: the effects of thrombospondin-1 and -2.

Authors:  Jack Lawler; Michael Detmar
Journal:  Int J Biochem Cell Biol       Date:  2004-06       Impact factor: 5.085

10.  Plasma cellular-fibronectin concentration predicts hemorrhagic transformation after thrombolytic therapy in acute ischemic stroke.

Authors:  Mar Castellanos; Rogelio Leira; Joaquín Serena; Miguel Blanco; Salvador Pedraza; José Castillo; Antoni Dávalos
Journal:  Stroke       Date:  2004-05-27       Impact factor: 7.914

View more
  22 in total

1.  Gabapentin attenuates hyperexcitability in the freeze-lesion model of developmental cortical malformation.

Authors:  Lauren Andresen; David Hampton; Amaro Taylor-Weiner; Lydie Morel; Yongjie Yang; Jamie Maguire; Chris G Dulla
Journal:  Neurobiol Dis       Date:  2014-08-23       Impact factor: 5.996

2.  2013 Thomas Willis Award Lecture: Causation and collaboration for stroke research.

Authors:  Eng H Lo
Journal:  Stroke       Date:  2013-11-07       Impact factor: 7.914

3.  Circulating leucocytes perpetuate stroke-induced aortic dysfunction.

Authors:  Shinichi Asano; Grant C O'Connell; Kent C Lemaster; Evan R DeVallance; Kayla W Branyan; James W Simpkins; Jefferson C Frisbee; Taura L Barr; Paul D Chantler
Journal:  Exp Physiol       Date:  2017-09-02       Impact factor: 2.969

4.  Basement membrane and stroke.

Authors:  Yao Yao
Journal:  J Cereb Blood Flow Metab       Date:  2018-09-18       Impact factor: 6.200

Review 5.  Application of proteomics to cerebrovascular disease.

Authors:  Mingming Ning; Mary Lopez; Jing Cao; Ferdinando S Buonanno; Eng H Lo
Journal:  Electrophoresis       Date:  2012-12       Impact factor: 3.535

6.  Thrombospondin-1 is a novel negative regulator of liver regeneration after partial hepatectomy through transforming growth factor-beta1 activation in mice.

Authors:  Hiromitsu Hayashi; Keiko Sakai; Hideo Baba; Takao Sakai
Journal:  Hepatology       Date:  2012-03-18       Impact factor: 17.425

7.  From Analysis of Ischemic Mouse Brain Proteome to Identification of Human Serum Clusterin as a Potential Biomarker for Severity of Acute Ischemic Stroke.

Authors:  Hailong Song; Hui Zhou; Zhe Qu; Jie Hou; Weilong Chen; Weiwu Cai; Qiong Cheng; Dennis Y Chuang; Shanyan Chen; Shuwei Li; Jilong Li; Jianlin Cheng; C Michael Greenlief; Yuan Lu; Agnes Simonyi; Grace Y Sun; Chenghan Wu; Jiankun Cui; Zezong Gu
Journal:  Transl Stroke Res       Date:  2018-11-21       Impact factor: 6.829

Review 8.  Stroke-related translational research.

Authors:  Louis R Caplan; Juan Arenillas; Steven C Cramer; Anne Joutel; Eng H Lo; James Meschia; Sean Savitz; Elizabeth Tournier-Lasserve
Journal:  Arch Neurol       Date:  2011-05-09

9.  Effects of aging, hypertension and diabetes on the mouse brain and heart vasculomes.

Authors:  Shuzhen Guo; Wenjun Deng; Changhong Xing; Yiming Zhou; MingMing Ning; Eng H Lo
Journal:  Neurobiol Dis       Date:  2018-07-19       Impact factor: 5.996

10.  Proteomic Analysis and Biochemical Correlates of Mitochondrial Dysfunction after Low-Intensity Primary Blast Exposure.

Authors:  Hailong Song; Mei Chen; Chen Chen; Jiankun Cui; Catherine E Johnson; Jianlin Cheng; Xiaowan Wang; Russell H Swerdlow; Ralph G DePalma; Weiming Xia; Zezong Gu
Journal:  J Neurotrauma       Date:  2019-01-14       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.